# Acute Consequences of Glucocorticoid Secretion in Overweight and Obese Individuals During Maximum Calorie Intake

> **NCT06556277** · NA · COMPLETED · sponsor: **Eleonora Seelig** · enrollment: 23 (actual)

## Conditions studied

- Glucocorticoids
- Overweight and Obesity
- Overeating

## Interventions

- **DRUG:** Metyrapone And Hydrocortisone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06556277
- **Lead sponsor:** Eleonora Seelig
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-09-01
- **Primary completion:** 2026-02-25
- **Final completion:** 2026-02-25
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06556277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06556277, "Acute Consequences of Glucocorticoid Secretion in Overweight and Obese Individuals During Maximum Calorie Intake". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06556277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
